CLASS II Device recall · Reported 16 Dec 2020 · FDA Enforcement Report

Rom Plus Collection Kit Ifu recalled by Clinical Innovations

Clinical Innovations is recalling Rom Plus Collection Kit Ifu: Rom Plus Rupture of Membrane Test Rom-5025, Rom-6025, distributed in 8 states. The recall was initiated on 13 Aug 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel Number: ROM-5025 Lot Number: 192438 Model Number: ROM-6025 Lot Numbers: 192353, 192359, 192631
Quantity recalled19450 units/kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0541-2021
FDA event ID
86255
Recalling firm
Clinical Innovations, Murray, UT
Classification
Class II
Status
Terminated
Recall initiated
13 Aug 2020
FDA classified
7 Dec 2020
Reported
16 Dec 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

13 Aug 2020Recall initiated by company
7 Dec 2020Classified by FDA+116 days
16 Dec 2020Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Possible false negative or false positive results. The incorrect sample collection swabs (non-scored) were assembled into assembled into the in vitro diagnostic kits. If the user does not break the swab stick correctly, or if scissors or other tools are used to cut the swab handle false negative or false positive results can occur.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Clinical Innovations ROM Plus Collection Kit IFU: ROM Plus Rupture of Membrane Test ROM-5025, ROM-6025

Where it was distributed

US: CO, IL, IN, MO, OH, RI, UT, and VA. OUS: None

ColoradoIllinoisIndianaMissouriOhioRhode IslandUtahVirginia

Questions about this recall

Why was it recalled?

Possible false negative or false positive results. The incorrect sample collection swabs (non-scored) were assembled into assembled into the in vitro diagnostic kits. If the user does not break the swab stick correctly, or if scissors or other tools are used to cut the swab handle false negative or false positive results can occur.

Which lots are affected?

Model Number: ROM-5025 Lot Number: 192438 Model Number: ROM-6025 Lot Numbers: 192353, 192359, 192631

Where was it sold?

US: CO, IL, IN, MO, OH, RI, UT, and VA. OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Clinical Innovations

All 9

Other Other Medical Devices recalls

All 13,908